BBIO
BridgeBio Pharma Inc
66.60$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -79.7% | +745.1% | +11.4% | -88.0% | +2,285.3% | +126.3% | |
| – | – | – | +23.5% | +0.8% | +10.3% | -28.8% | +58.5% | +629.1% | |
| – | – | – | -78.3% | +707.4% | +11.4% | -90.8% | +3,079.6% | +117.3% | |
| – | +358.4% | +49.9% | +60.5% | +33.8% | -11.4% | +14.1% | +11.1% | -5.7% | |
| – | +227.7% | +116.5% | +54.4% | +31.9% | -25.5% | +5.2% | +66.6% | +111.7% | |
| – | +318.8% | +65.7% | +58.6% | +33.2% | -8.8% | +4.7% | +32.0% | +28.6% | |
| – | – | – | – | – | – | – | – | – | |
| – | +19,492.3% | +244.1% | +318.2% | +27.6% | +72.0% | +1.1% | +22.1% | -46.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | -268.0% | – | – | -82.4% | +667.9% | -98.4% | -51.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.